Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.76 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.76 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.70 |
| ▸ | GABRA1 | P14867 | 5/20 | 0.64 |
| ▸ | GABRB2 | P47870 | 5/20 | 0.64 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.64 |
| ▸ | MAOB | P27338 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.64 |
| ▸ | NPC1 | O15118 | 1/20 | 0.64 |
| ▸ | CTSD | P07339 | 1/20 | 0.64 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.64 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.64 |
| ▸ | MAOA | P21397 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
| ▸ | DHODH | Q02127 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11441141 | 1.00 | HSD17B10 (0.76) | HSD17B10CYP1A2HDAC6GABRA1GABRB2 | |
| SCHEMBL28583726 | 1.00 | HSD17B10 (0.76) | HSD17B10CYP1A2HDAC6GABRA1GABRB2 | |
| SCHEMBL11458656 | 1.00 | HSD17B10 (0.76) | HSD17B10CYP1A2HDAC6GABRA1GABRB2 | |
| Fumaric Acid SCHEMBL635750 | 0.94 | HSD17B10 (0.82) | HSD17B10CYP1A2HDAC6GABRA1GABRB2 | |
| Maleic Acid SCHEMBL635748 | 0.94 | HSD17B10 (0.82) | HSD17B10CYP1A2HDAC6GABRA1GABRB2 | |
| SCHEMBL196821 | 0.89 | KDM4E (0.66) | HSD17B10CYP1A2HDAC6TRPV1CYP3A4 | |
| SCHEMBL196822 | 0.89 | KDM4E (0.66) | HSD17B10CYP1A2HDAC6TRPV1CYP3A4 | |
| SCHEMBL25423911 | 0.88 | HSD17B10 (0.72) | HSD17B10CYP1A2HDAC6GABRA1GABRB2 | |
| Piperic Acid SCHEMBL447578 | 0.86 | HSD17B10 (1.00) | HSD17B10CYP1A2HDAC6GABRA1GABRB2 | |
| Piperic Acid SCHEMBL11460093 | 0.86 | HSD17B10 (1.00) | HSD17B10CYP1A2HDAC6GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4683527-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2026-01-28 | — | — | EP | claimed |
| US-12497381-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-12-16 | — | — | US | claimed |
| US-12478091-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-11-25 | — | — | US | claimed |
| US-12358889-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-07-15 | — | — | US | claimed |
| US-12358888-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-07-15 | — | — | US | claimed |
| WO-2025096261-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2025-05-08 | — | — | WO | claimed |
| WO-2025049141-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2025-03-06 | — | — | WO | claimed |
| US-20250049096-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2025-02-13 | — | — | US | claimed |
| US-20240400539-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2024-12-05 | — | — | US | claimed |
| CN-118984653-A | Vaporizable alkaloid compositions and methods of use thereof | 瑞迪美天然有限公司 | 2024-11-19 | — | — | CN | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| WO-1994008840-A1 | MARINE ORGANISM REPELLENT FOR PROTECTING UNDERWATER OBJECTS | FISCHER KENNETH J (US) | 1994-04-28 | — | — | WO | claimed |
| EP-0002735-B1 | PROCESS FOR THE PREPARATION OF PIPERONYLIDENECROTON AMIDES | HAARMANN & REIMER GMBH (DE) | 1980-12-10 | — | — | EP | claimed |
| EP-0002734-B1 | PROCESS FOR THE PREPARATION OF PIPERONYLIDENECROTON AMIDES | HAARMANN & REIMER GMBH (DE) | 1980-09-17 | — | — | EP | claimed |
| US-4209446-A | FROM PIPERONAL AND A CROTONIC AMIDE IN PRESENCE OF ALKALI METAL HYDROXIDE AND DIPOLAR APROTIC DILUENT | HAARMAN & REIMER GMBH (DE) | 1980-06-24 | — | — | US | claimed |
| US-4209445-A | FROM PIPERONAL AND A CROTONIC AMIDE IN PRESENCE OF QUATERNARY AMMONIUM OR PHOSPHONIUM HYDROXIDE OR CROWN ETHER METAL COMPLEX | HAARMAN & REIMER GMBH (DE) | 1980-06-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400539-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | CHRM5, NNMT, CHRM1 | HSD17B10 2049/4885CYP1A2 223/4885HDAC6 2562/4885 |
| US-12358888-B2 | Vaporizable alkaloid compositions and methods of use thereof | SRM, SCLY, SMOX | HSD17B10 3350/4885CYP1A2 1183/4885HDAC6 3736/4885 |
| US-12358889-B2 | Vaporizable alkaloid compositions and methods of use thereof | SRM, SCLY, SMOX | HSD17B10 3350/4885CYP1A2 1183/4885HDAC6 3736/4885 |
| US-12497381-B2 | Vaporizable alkaloid compositions and methods of use thereof | CHRM5, NNMT, CHRM1 | HSD17B10 2049/4885CYP1A2 223/4885HDAC6 2562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.